AU1273499A - 148 human secreted proteins - Google Patents
148 human secreted proteinsInfo
- Publication number
- AU1273499A AU1273499A AU12734/99A AU1273499A AU1273499A AU 1273499 A AU1273499 A AU 1273499A AU 12734/99 A AU12734/99 A AU 12734/99A AU 1273499 A AU1273499 A AU 1273499A AU 1273499 A AU1273499 A AU 1273499A
- Authority
- AU
- Australia
- Prior art keywords
- secreted proteins
- human secreted
- human
- proteins
- secreted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Applications Claiming Priority (35)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6310097P | 1997-10-24 | 1997-10-24 | |
| US6310197P | 1997-10-24 | 1997-10-24 | |
| US6309897P | 1997-10-24 | 1997-10-24 | |
| US6278497P | 1997-10-24 | 1997-10-24 | |
| US6308897P | 1997-10-24 | 1997-10-24 | |
| US6338797P | 1997-10-24 | 1997-10-24 | |
| US6309197P | 1997-10-24 | 1997-10-24 | |
| US6309997P | 1997-10-24 | 1997-10-24 | |
| US6309297P | 1997-10-24 | 1997-10-24 | |
| US6311097P | 1997-10-24 | 1997-10-24 | |
| US6310997P | 1997-10-24 | 1997-10-24 | |
| US6311197P | 1997-10-24 | 1997-10-24 | |
| US6309797P | 1997-10-24 | 1997-10-24 | |
| US6309097P | 1997-10-24 | 1997-10-24 | |
| US6308997P | 1997-10-24 | 1997-10-24 | |
| US6314897P | 1997-10-24 | 1997-10-24 | |
| US6338697P | 1997-10-24 | 1997-10-24 | |
| US60063090 | 1997-10-24 | ||
| US60063099 | 1997-10-24 | ||
| US60063109 | 1997-10-24 | ||
| US60063089 | 1997-10-24 | ||
| US60063387 | 1997-10-24 | ||
| US60063148 | 1997-10-24 | ||
| US60063101 | 1997-10-24 | ||
| US60062784 | 1997-10-24 | ||
| US60063100 | 1997-10-24 | ||
| US60063092 | 1997-10-24 | ||
| US60063110 | 1997-10-24 | ||
| US60063088 | 1997-10-24 | ||
| US60063386 | 1997-10-24 | ||
| US60063098 | 1997-10-24 | ||
| US60063097 | 1997-10-24 | ||
| US60063091 | 1997-10-24 | ||
| US60063111 | 1997-10-24 | ||
| PCT/US1998/022376 WO1999022243A1 (en) | 1997-10-24 | 1998-10-23 | 148 human secreted proteins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU1273499A true AU1273499A (en) | 1999-05-17 |
Family
ID=27586006
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU12734/99A Abandoned AU1273499A (en) | 1997-10-24 | 1998-10-23 | 148 human secreted proteins |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1042674A4 (de) |
| JP (1) | JP2003521865A (de) |
| AU (1) | AU1273499A (de) |
| CA (1) | CA2307320A1 (de) |
| WO (1) | WO1999022243A1 (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001034623A1 (en) * | 1999-11-05 | 2001-05-17 | Human Genome Sciences, Inc. | 29 human secreted proteins |
| US20020137890A1 (en) * | 1997-03-31 | 2002-09-26 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| CA2363684A1 (en) * | 1999-03-05 | 2000-09-08 | Incyte Pharmaceuticals, Inc. | Human secretory proteins |
| US6331413B1 (en) | 1999-03-17 | 2001-12-18 | Zymogenetics, Inc. | Secreted salivary ZSIG63 Polypeptide |
| WO2000071581A1 (fr) * | 1999-05-20 | 2000-11-30 | Takeda Chemical Industries, Ltd. | Nouveau polypeptide |
| FR2796652B1 (fr) * | 1999-07-20 | 2003-03-21 | Inst Nat Sante Rech Med | Acides nucleiques codant pour des peptides possedant l'activite biologique de la sorbine |
| AU1922301A (en) * | 1999-11-17 | 2001-05-30 | Nyxis Neurotherapies, Inc. | Differential gene expression in cancer |
| AU2001253487A1 (en) * | 2000-04-13 | 2001-10-30 | Millennium Pharmaceuticals, Inc. | 23155 novel protein human 5-alpha reductases and uses therefor |
| EP1322657A4 (de) * | 2000-09-12 | 2004-12-29 | Human Genome Sciences Inc | 22 humane sezernierte proteine |
| AU2003294236A1 (en) * | 2002-10-25 | 2004-05-25 | Five Prime Therapeutics, Inc. | Methods of use for novel human polypeptides encoded by polynucleotides |
| TW201100090A (en) * | 2009-04-01 | 2011-01-01 | Oncotherapy Science Inc | C6orf167 peptides and vaccines containing the same |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5597709A (en) * | 1994-01-27 | 1997-01-28 | Human Genome Sciences, Inc. | Human growth hormone splice variants hGHV-2(88) and hGHV-3(53) |
| AU710568B2 (en) * | 1994-12-09 | 1999-09-23 | Human Genome Sciences, Inc. | Human vascular IBP-like growth factor |
| EP0833914A4 (de) * | 1995-06-05 | 2003-05-28 | Human Genome Sciences Inc | Menschliches chemokine beta-11 und alpha-1 |
-
1998
- 1998-10-23 EP EP98956146A patent/EP1042674A4/de not_active Withdrawn
- 1998-10-23 CA CA002307320A patent/CA2307320A1/en not_active Abandoned
- 1998-10-23 JP JP2000518285A patent/JP2003521865A/ja not_active Withdrawn
- 1998-10-23 WO PCT/US1998/022376 patent/WO1999022243A1/en not_active Application Discontinuation
- 1998-10-23 AU AU12734/99A patent/AU1273499A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1042674A1 (de) | 2000-10-11 |
| EP1042674A4 (de) | 2005-03-23 |
| WO1999022243A1 (en) | 1999-05-06 |
| CA2307320A1 (en) | 1999-05-06 |
| JP2003521865A (ja) | 2003-07-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU6552198A (en) | 28 human secreted proteins | |
| AU4682999A (en) | 94 human secreted proteins | |
| AU5134799A (en) | 98 human secreted proteins | |
| AU2577799A (en) | 45 human secreted proteins | |
| AU2306499A (en) | 110 human secreted proteins | |
| EP1039801A4 (de) | 207 menschliche sekretierte proteine | |
| EP1000084A4 (de) | 123 vom menschen abgesonderte proteine | |
| AU5583799A (en) | 49 human secreted proteins | |
| AU6952998A (en) | 20 human secreted proteins | |
| AU3124000A (en) | 47 human secreted proteins | |
| AU2471899A (en) | 67 human secreted proteins | |
| AU5796298A (en) | Secreted human proteins | |
| AU9130498A (en) | 50 human secreted proteins | |
| AU8066998A (en) | 86 human secreted proteins | |
| AU2451199A (en) | 36 human secreted proteins | |
| EP1005544A4 (de) | 70 menschliche, sekretierte proteine | |
| AU5212299A (en) | 71 human secreted proteins | |
| AU5928899A (en) | 31 human secreted proteins | |
| AU1231400A (en) | 12 human secreted proteins | |
| AU8404598A (en) | 64 human secreted proteins | |
| EP1032838A4 (de) | 125 menschliche sekretierte proteine | |
| AU3006799A (en) | 31 human secreted proteins | |
| EP1009766A4 (de) | 19 menschlisch, sekretierte proteine | |
| AU1273499A (en) | 148 human secreted proteins | |
| EP1002132A4 (de) | Humane sekretierte proteine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |